Pfizer's Zoetis Surges in Trading Debut After $2.24 Billion IPO

Juan Ramon Alaix, chief executive officer of Zoetis, third left, applauds while ringing the opening bell on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Friday, Feb. 1, 2013. Zoetis Inc., the animal-health company owned by Pfizer Inc., surged as much as 22 percent in its debut after raising $2.24 billion in its initial public offering, pricing the shares above the proposed price range. Photographer: Jin Lee/Bloomberg via Getty Images
Juan Ramon Alaix, chief executive officer of Zoetis, third left, applauds while ringing the opening bell on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Friday, Feb. 1, 2013. Zoetis Inc., the animal-health company owned by Pfizer Inc., surged as much as 22 percent in its debut after raising $2.24 billion in its initial public offering, pricing the shares above the proposed price range. Photographer: Jin Lee/Bloomberg via Getty Images
Pfizer's Zoetis Surges in Trading Debut After $2.24 Billion IPO
ACHETER UNE LICENCE
Comment puis-je utiliser cette image ?
475,00 €
EUR

INFORMATIONS

Restrictions :
Contactez votre agence locale pour toute utilisation commerciale ou promotionnelle.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédits :
Bloomberg / Contributeur
Editorial - n° :
160478976
Collection :
Bloomberg
Date de création :
1 février 2013
Date de chargement :
Type de licence :
Droits gérés
Infos autorisations :
Autorisation non disponible. Plus d'infos
Source :
Bloomberg
Référence :
ZOETIS SHARES